But often, when the moment to use the auto-injector, most of them (or the people around them) often don't know how to use it, and can't even be sure if it is still good to use (epinephrine can't remain potent for very long, and therefore has some of the shortest expiration dates in the drug industry, at around 18 months). Realising that carrying an auto-injector was not enough to save lives, Anna Sala, an allergy specialist MD living in Barcelona got together with an Internal Medicine Specialist MD, Adrián Curran, to develop something better: the anAPPhylaxis.
APPhylaxis consists of a smart case (which holds the injector) and an acommpanying mobile phone app. While the case keeps the volatile substances inside the injector protected from light and impact, it will also keep track of whether its still in date, and thanks to a bluetooth connection to the app, it can even warn you if you forget it.
The accompanying app also helps the patient to know what to do during an allergic reaction. Not only does it automatically alert the emergency services and/or the predetermined contacts and provide the patient's exact location, but it also plays a video explaining how to use the auto-injector so even the person assisting will be able to use it. There is also a comic that explains how to use it.
“There isn’t anything in the market like what we have created—an innovative and effortless device that pairs biotechnology and mobile health,” says Adan MI CEO Xavier Guillem. “This convergence of these two fields is groundbreaking, and we are only just beginning to implement the potential of this technology.”
After a successful clinical trial in one of the biggest hospitals in Europe to evaluate its usefulness, the team is currently preparing to launch it to market while working on other series of products under the same aim: using new technologies and IoT to help to improve patients' lives.